Evidence for the mechanism by which eicosapentaenoic acid inhibits human platelet aggregation and secretion - implications for the prevention of vascular disease.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000818:Animals; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000378:metabolism*; D000001:Calcimycin / Q000494:pharmacology; D003094:Collagen / Q000494:pharmacology; D004537:Eicosanoic Acids / Q000494:pharmacology*; D004837:Epinephrine / Q000494:pharmacology; D011464:Epoprostenol / Q000096:biosynthesis; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology*; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects*; D051381:Rats; D014652:Vascular Diseases / Q000517:prevention & control*
D004537:Eicosanoic Acids; D005231:Fatty Acids, Unsaturated; D000001:Calcimycin; D000244:Adenosine Diphosphate; D003094:Collagen; D011464:Epoprostenol; D001241:Aspirin; D004837:Epinephrine